NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Bfflist AMO? Mail in a sample (US only) and let us test it.

Test my supply
71%
Finnrick rating
#295 of 500 ranked vendors
56 of 76 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Bfflist AMO's purity-focus record is strongest in Retatrutide, where many recent tests pass but fill outliers keep the signal uneven. Tirzepatide has turned more volatile after earlier clean results, while Cagrilintide and thinly tested Semaglutide show repeated purity or quantity misses with batch consistency caveats.

methodology →
vendor intelligence report
Vendor Intelligence Report: Bfflist AMO

The investigation maps a domain-pivot trail from Amo/BFF history to a newer crypto-only shop while bfflist.org sits parked and for sale. COA cards, payment rails, and registry searches expose verification gaps the storefront does not resolve.

34 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.63
85%
50
2
Tirzepatide
$0.36
70%
17
4
Cagrilintide
$1.56
43%
6
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Jan 2026: 70%7 Jan 2026: 71%7 Jan 2026: 71%7 Jan 2026: 71%15 Jan 2026: 71%15 Jan 2026: 72%15 Jan 2026: 72%22 Jan 2026: 72%22 Jan 2026: 72%22 Jan 2026: 72%22 Jan 2026: 71%26 Jan 2026: 72%26 Jan 2026: 72%26 Jan 2026: 72%29 Jan 2026: 73%29 Jan 2026: 73%29 Jan 2026: 73%29 Jan 2026: 73%2 Feb 2026: 72%4 Feb 2026: 72%11 Feb 2026: 72%11 Feb 2026: 73%13 Feb 2026: 73%15 Feb 2026: 73%16 Feb 2026: 73%16 Feb 2026: 74%18 Feb 2026: 74%18 Feb 2026: 73%18 Feb 2026: 72%18 Feb 2026: 71%18 Feb 2026: 72%18 Mar 2026: 71%21 Mar 2026: 72%29 Mar 2026: 72%21 Apr 2026: 72%23 Apr 2026: 71%15 Jul 2026: 71%6 Oct 2026: 72%2 Nov 2026: 70%5 Nov 2026: 70%17 Nov 2026: current 71%70%72%71%Jan 26Nov 26
Peptide testing

Ordered peptides from Bfflist AMO? Mail in a sample (US only) and let us test it.

Test my supply
Bfflist AMO test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
5 Nov 2026
Pass
Retatrutide
lab nameView COA
2 Nov 2026
Fail
Retatrutide
lab nameView COA
6 Oct 2026
Pass
Tirzepatide
lab nameView COA
15 Jul 2026
Pass
Retatrutide
lab nameView COA
23 Apr 2026
Fail
Tirzepatide
lab nameView COA
21 Apr 2026
Pass
Retatrutide
lab nameView COA
29 Mar 2026
Pass
Retatrutide
lab nameView COA
21 Mar 2026
Pass
Cagrilintide
lab nameView COA
18 Mar 2026
Fail
Cagrilintide
lab nameView COA
18 Feb 2026
Fail
Tirzepatide
lab nameView COA
1-10 of 76

About Bfflist AMO test results from Finnrick

Bfflist AMO is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 76 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Bfflist AMO peptides in this dataset are Cagrilintide (6 tests), Retatrutide (50 tests) and Semaglutide (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 76 recent tests. It also includes 1 correction related to this vendor.

Corrections
2025-11-05
Lab correction
These were remade and reanalyzed by Lab G. They traced the discrepancy to a likely human error during preparation.
Peptide testing

Ordered peptides from Bfflist AMO? Mail in a sample (US only) and let us test it.

Test my supply